INTRODUCTION

The use of mycophenolate mofetil in the treatment of steroid resistant minimal change disease has not been extensively studied, particularly in the African Caribbean population. This drug has fewer side effects than most immunosuppressants. On this basis, it may be preferred by both patient and physician. This case report highlights its use in a patient with minimal change nephrosis.